Clinical Trials & Research Studies
Breast cancer clinical trials, also called clinical studies, are a type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis or treatment.
In this section, get basic information about breast cancer clinical trials for women diagnosed with triple-negative breast cancer, explore whether taking part in a clinical trial is right for you and find studies you may be eligible to participate in.
You can also get information and updates on other breast cancer research studies that follow participants over time to determine treatment outcomes.
The BROCADE study needs men and women with metastatic breast cancer and a BRCA1 or BRCA2 gene mutation for a phase II clinical trial. The trial team will assess how safe and effective a new targeted therapy is when combined with one or more common chemotherapy medicines.
Researchers seek 240 women with metastatic, triple-negative breast cancer for a phase II study assessing the safety of different chemotherapy combinations and how well they prevent the worsening of the disease.
The Step by Step research study is recruiting women affected by breast cancer for a free, 12-week walking program facilitated online.